• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria News / Sanaria Announces Products for Malaria Research

Sanaria Announces Products for Malaria Research

June 29, 2011 By Malaria.com Leave a Comment

Biotechnology company Sanaria has announced the launch of a suite of products intended to advance research towards new malaria vaccines, drugs, and diagnostics, and enhanced understanding of malaria pathology and immunobiology.

Sanaria’s mission is to develop and commercialize wholeparasite malaria vaccines that confer high-level, long-lasting protection against malaria caused by Plasmodium falciparum and P. vivax.

In the process of developing these vaccines, Sanaria has developed the capacity to manufacture and assay malaria parasites and mosquitoes in a highly regulated, cGMP compliant, industrial setting.

The company has announced that these parasites, mosquitoes, and assay services are now available to the general research community:

  • Sanaria Plasmodium falciparum Sporozoite Reagents: Aseptic, purified, vialed, cryopreserved, attenuated and non-attenuated Plasmodium falciparum (Pf) sporozoites.
  • Sanaria PfSPZ Challenge Mosquitoes: Live, aseptic and non-aseptic P. falciparum infected mosquitoes. These well-characterized mosquitoes are for experimentally challenging volunteers in studies assessing malaria vaccines and drugs and for laboratory-based research.
  • Sanaria Plasmodium Reagents: Purified, vialed, cryopreserved, attenuated and nonattenuated Plasmodium species sporozoites, as well as other life cycle stages for laboratory-based research studies.
  • Sanaria Plasmodium Reagent Slides: Slides for immunofluorescence assays to
    detect antibodies against purified sporozoite, and asexual erythrocytic, sexual
    erythrocytic and/or mosquito stages of Plasmodium species.
  • Sanaria Anopheles Reagents: Aseptic and non-aseptic Anopheles stephensi
    mosquitoes and derived material for laboratory-based research studies.
  • Sanaria Plasmodium Assay Services: Assessment of the effects of antibodies and
    drugs on the capacity of P. falciparum and P. vivax sporozoites to invade and develop in
    hepatocytes (inhibition of sporozoite invasion and inhibition of liver stage development
    assay), and of P. falciparum gametocytes to develop to oocysts and sporozoites in
    mosquitoes (transmission blocking assay). Assessment of antibodies to all life cycle
    stages of Plasmodium species by immunofluoresence assays and to selected antigens
    by ELISA.
  • Monoclonal Antibodies: Sporozoite, liver, and blood stage monoclonal antibodies.
  • Sanaria Custom Services: Sanaria will manufacture Plasmodium species reagents to
    meet client specifications.

Source: Sanaria

Filed Under: Malaria News Tagged With: Anopheles Reagents, Monoclonal Antibodies, PfSPZ Challenge Mosquitoes, Plasmodium Assay Services, Plasmodium falciparum Sporozoite, Plasmodium Reagents, Sanaria

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com · Log in